The report is titled ‘Genome Editing Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the Genome Editing market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. Genome editing market is expected to grow at a significant rate in the near future.
The global genome editing market in 2020 is estimated for more than US$ 2.4 Bn and expected to reach a value of US$ 14.5 Bn by 2028 with a significant CAGR of 25.3%.
Genome Editing Market Definition
Genome editing is a method of making definite variations to the DNA of an organism or cell. The method of genome editing involves cutting the particular DNA sequence with an engineered nucleus, more commonly known as an enzyme.
The main purpose of genome editing is to add, cut down, or amend DNA in the genome that results in changes in the features of an organism or cell. The method of genome editing can be applied to any kind of organism to alter the DNA in the genome,
However, it is wrongful and prohibited to practice genome editing on human embryos. Although genome editing finds applications in numerous industries such as in biotechnology, for research and development activities as well as it can promote its utility in treating some severe diseases. Thus, the genome editing market is expected to observe substantial growth in the near future.
Genome Editing Market Dynamics
The increased research and development activities these days are majorly contributing to the growth of the global genome editing market, as genome editing serves its utility in altering the DNA in organisms or cells in order to get the picture of their biology and their work. Along with that, genomic editing also serves in treating various chronic diseases such as AIDS, leukemia, MRSA, hemophilia, muscular dystrophy, and many more as it carries the potential to customize the human blood cells that are then put back into the body.
Owing to this, the global genome editing market is expected to witness significant growth in the forthcoming future By the same token, the employment of the method in the accomplishment of therapeutic genome editing in contaminated or affected tissues or cells, thereby eliminating the harmful variation is also expected to give a positive boost to the growth of the global genome editing market in the near future.
In addition to that, the soaring count of partnerships, collaborations, and acquisitions in biotechnological and pharmaceutical companies in the present-day world is also contributing to the growing number of research activities, thus increasing the applications for genome editing in the upcoming future. Thus, the global genome editing market is projected to elevate positively during the forecast timeframe.
Genome Editing Market Key Players
Some of the key participating players in the genome editing market are
Thermo Fisher Scientific
Merck
Horizon Discovery Group
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Genome Editing Market Segmentation
The global genome editing market is segmented on the basis of technology, application, end-user, and region.
By Technology
CRISPR
TALEN
ZFN
Antisense
Other Technologies
By Application
Cell line Engineering
Genetic Engineering
Other Applications
By End-User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
MMC Overview on Genome Editing Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give a better opportunity for the customers to put their effort.
A research report on the genome editing market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support the market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth include (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Genome Editing
• Advantage of Genome Editing
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at a regional level and in major countries globally for providing regional insights into the product segment in the report. This helps our clients to make an informed decision.
A mix of top-down and bottom-up approach is followed to arrive at and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, its product sales, previous growth rates, and market expansion plans are considered to generate market share in the global market.
1. Global Genome Editing Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Genome Editing Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Genome Editing Market Snapshot
2.4. Global Genome Editing Market Size and Forecast, 2019–2027
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2019–2027)
2.5. Global Genome Editing Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Genome Editing Market, By Technology
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Technology
3.1.2. BPS Analysis, By Technology
3.2. Market Revenue (US$Mn) Forecast, By Technology
3.2.1. CRISPR
3.2.2. TALEN
3.2.3. ZFN
3.2.4. Antisense
3.2.5. Other technologies
3.3. Global Genome Editing Market Attractiveness Index, By Technology
4. Global Genome Editing Market, By Application
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Application
4.1.2. BPS Analysis, By Application
4.2. Market Revenue (US$Mn) Forecast, By Application
4.2.1. Cell line Engineering
4.2.2. Genetic Engineering
4.2.3. Other Applications
4.3. Global Genome Editing Market Attractiveness Index, By Application
5. Global Genome Editing Market, By End User
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By End User
5.1.2. BPS Analysis, By End User
5.2. Market Revenue (US$Mn) Forecast, By End User
5.2.1. Pharmaceutical & Biotechnology Companies
5.2.2. Academic & Research Institutes
5.2.3. Contract Research Organizations
5.3. Global Genome Editing Market Attractiveness Index, By End User
6. Global Genome Editing Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Genome Editing Market Attractiveness Index, By Region
7. North America Genome Editing Market Analysis and Forecast, 2019–2027
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Genome Editing Market
7.2.2. Canada Genome Editing Market
7.3. North America Genome Editing Market, By Technology
7.3.1. CRISPR
7.3.2. TALEN
7.3.3. ZFN
7.3.4. Antisense
7.3.5. Other technologies
7.4. North America Genome Editing Market, By Application
7.4.1. Cell line Engineering
7.4.2. Genetic Engineering
7.4.3. Other Applications
7.5. North America Genome Editing Market, By End User
7.5.1. Pharmaceutical & Biotechnology Companies
7.5.2. Academic & Research Institutes
7.5.3. Contract Research Organizations
7.6. North America Genome Editing Market Attractiveness Index
7.6.1. By Country
7.6.2. By Technology
7.6.3. By Application
7.6.4. By End User
8. Latin America Genome Editing Market Analysis and Forecast, 2019–2027
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Genome Editing Market
8.2.2. Mexico Genome Editing Market
8.2.3. Argentina Genome Editing Market
8.2.4. Rest of Latin America Genome Editing Market
8.3. Latin America Genome Editing Market, By Technology
8.3.1. CRISPR
8.3.2. TALEN
8.3.3. ZFN
8.3.4. Antisense
8.3.5. Other technologies
8.4. Latin America Genome Editing Market, By Application
8.4.1. Cell line Engineering
8.4.2. Genetic Engineering
8.4.3. Other Applications
8.5. Latin America Genome Editing Market, By End User
8.5.1. Pharmaceutical & Biotechnology Companies
8.5.2. Academic & Research Institutes
8.5.3. Contract Research Organizations
8.6. Latin America Genome Editing Market Attractiveness Index
8.6.1. By Country
8.6.2. By Technology
8.6.3. By Application
8.6.4. By End User
9. Europe Genome Editing Market Analysis and Forecast, 2019–2027
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Genome Editing Market
9.2.2. Germany Genome Editing Market
9.2.3. Italy Genome Editing Market
9.2.4. France Genome Editing Market
9.2.5. Spain Genome Editing Market
9.2.6. Russia Genome Editing Market
9.2.7. Poland Genome Editing Market
9.2.8. BENELUX Genome Editing Market
9.2.9. NORDIC Genome Editing Market
9.2.10. Rest of Europe Genome Editing Market
9.3. Europe Genome Editing Market, By Technology
9.3.1. CRISPR
9.3.2. TALEN
9.3.3. ZFN
9.3.4. Antisense
9.3.5. Other technologies
9.4. Europe Genome Editing Market, By Application
9.4.1. Cell line Engineering
9.4.2. Genetic Engineering
9.4.3. Other Applications
9.5. Europe Genome Editing Market, By End User
9.5.1. Pharmaceutical & Biotechnology Companies
9.5.2. Academic & Research Institutes
9.5.3. Contract Research Organizations
9.6. Europe Genome Editing Market Attractiveness Index
9.6.1. By Country
9.6.2. By Technology
9.6.3. By Application
9.6.4. By End User
10. Asia Pacific Genome Editing Market Analysis and Forecast, 2019–2027
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Genome Editing Market
10.2.2. India Genome Editing Market
10.2.3. Japan Genome Editing Market
10.2.4. Australia and New Zealand Genome Editing Market
10.2.5. South Korea Genome Editing Market
10.2.6. ASEAN Genome Editing Market
10.2.7. Rest of Asia Pacific Genome Editing Market
10.3. Asia Pacific Genome Editing Market, By Technology
10.3.1. CRISPR
10.3.2. TALEN
10.3.3. ZFN
10.3.4. Antisense
10.3.5. Other technologies
10.4. Asia Pacific Genome Editing Market, By Application
10.4.1. Cell line Engineering
10.4.2. Genetic Engineering
10.4.3. Other Applications
10.5. Asia Pacific Genome Editing Market, By End User
10.5.1. Pharmaceutical & Biotechnology Companies
10.5.2. Academic & Research Institutes
10.5.3. Contract Research Organizations
10.6. Asia Pacific Genome Editing Market Attractiveness Index
10.6.1. By Country
10.6.2. By Technology
10.6.3. By Application
10.6.4. By End User
11. Middle East Genome Editing Market Analysis and Forecast, 2019–2027
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Genome Editing Market
11.2.2. Israel Genome Editing Market
11.2.3. Oman Genome Editing Market
11.2.4. Rest of Middle East Genome Editing Market
11.3. Middle East Genome Editing Market, By Technology
11.3.1. CRISPR
11.3.2. TALEN
11.3.3. ZFN
11.3.4. Antisense
11.3.5. Other technologies
11.4. Middle East Genome Editing Market, By Application
11.4.1. Cell line Engineering
11.4.2. Genetic Engineering
11.4.3. Other Applications
11.5. Middle East Genome Editing Market, By End User
11.5.1. Pharmaceutical & Biotechnology Companies
11.5.2. Academic & Research Institutes
11.5.3. Contract Research Organizations
11.6. Middle East Genome Editing Market Attractiveness Index
11.6.1. By Country
11.6.2. By Technology
11.6.3. By Application
11.6.4. By End User
12. Africa Genome Editing Market Analysis and Forecast, 2019–2027
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Genome Editing Market
12.2.2. Egypt Genome Editing Market
12.2.3. North Africa Genome Editing Market
12.2.4. Rest of Africa Genome Editing Market
12.3. Africa Genome Editing Market, By Technology
12.3.1. CRISPR
12.3.2. TALEN
12.3.3. ZFN
12.3.4. Antisense
12.3.5. Other technologies
12.4. Africa Genome Editing Market, By Application
12.4.1. Cell line Engineering
12.4.2. Genetic Engineering
12.4.3. Other Applications
12.5. Africa Genome Editing Market, By End User
12.5.1. Pharmaceutical & Biotechnology Companies
12.5.2. Academic & Research Institutes
12.5.3. Contract Research Organizations
12.6. Africa Genome Editing Market Attractiveness Index
12.6.1. By Country
12.6.2. By Technology
12.6.3. By Application
12.6.4. By End User
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Technology Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Merck
14.3.3. Horizon Discovery Group
14.3.4. Genscript
14.3.5. Sangamo Biosciences
14.3.6. Integrated Dna Technologies
14.3.7. Lonza
14.3.8. New England Biolabs
14.3.9. Origene Technologies
14.3.10. Transposagen Biopharmaceuticals
14.3.11. Editas Medicine
14.3.12. Crispr Therapeutics
15. Acronyms
Thermo Fisher Scientific
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Merck
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Horizon Discovery Group
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Genscript
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Sangamo Biosciences
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Integrated Dna Technologies
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Lonza
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
New England Biolabs
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Origene Technologies
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Transposagen Biopharmaceuticals
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Editas Medicine
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Crispr Therapeutics
• Company Overview
• Financial Overview
• Product Portfolio
• Key Developments
• Business Strategies
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global genome editing market in 2020 is estimated for more than US$ 2.4 Bn and expected to reach a value of US$ 14.5 Bn by 2028 with a significant CAGR of 25.3%.
What are the key factors driving the growth of market?
The increased research and development activities. Also, genomic editing also serves in treating various chronic diseases such as AIDS, leukemia, MRSA, hemophilia, muscular dystrophy, and many more as it carries the potential to customize the human blood cells that are then put back into the body.
What segments are covered in market report?
The global genome editing market is segmented on the basis of technology, application, end-user, and region.
What are the key participating players in the market?
Some of the key participating players in the genome editing market are Thermo Fisher Scientific, Merck, Horizon Discovery Group, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, and Crispr Therapeutics
